logo
RSA Announces New Innovations to Stop Help Desk Scams and Protect Passwordless Environments

RSA Announces New Innovations to Stop Help Desk Scams and Protect Passwordless Environments

Business Wire28-04-2025

SAN FRANCISCO--(BUSINESS WIRE)--RSA, the security-first identity leader, today announced groundbreaking cybersecurity innovations at RSAC Conference 2025 that defend organizations against the next wave of AI powered identity attacks, including IT Help Desk bypasses, malware, social engineering, and other threats. These advancements are especially critical for organizations implementing passwordless strategies and further solidify RSA's position as the only provider of true, enterprise-ready passwordless identity solutions.
Among the highlights is the new RSA ® Help Desk Live Verify (patent pending), a first-of-its-kind feature that prevents social engineering and technical support scams. With bi-directional identity verification, RSA Help Desk Live Verify ensures that both users and IT staff are who they say they are, protecting against attackers impersonating users or help desk agents.
'Passwordless approaches offer tantalizing business benefits like improved user experience and cost savings, but as with any new technology passwordless also introduces new risks into the environment. RSA's platform offers the only enterprise worthy passwordless solution that has security and resilience designed in to address those risks,' said RSA CEO Rohit Ghai. 'Off-the-rack passwordless isn't good enough for government agencies, financial services, and other security-first leaders.'
A New Enterprise Ready Passwordless Platform
RSA is approaching passwordless as a broader platform capability and not simply a convenient new form of authentication. While many vendors offer surface-level point products, RSA delivers comprehensive protection, unmatched resilience, and complete governance—addressing the full lifecycle and all users, from cloud to on-premises.
'Only RSA can provide a complete passwordless solution that accounts for every user, use case, and environment,' said Jim Taylor, Chief Product and Technology Officer at RSA. 'Organizations need comprehensive, enterprise-grade capabilities that are ready for social engineering, fraud, outages, and deepfakes—and RSA is delivering exactly that.'
For a passwordless solution to work for enterprises, it must work for every user, in every environment, against every threat, and in every situation. Unlike cloud-first or hardware-only providers, RSA offers passwordless capability across cloud, on-premises, hybrid, and legacy systems—ensuring every user and use case is covered.
RSA also ensures that passwordless access remains available even during internet outages with offline and secure fallback capabilities. RSA complements the widest breadth of supported passwordless protocols and form factors with the greatest security depth against threats like malware, brute force, phishing, and AiTM attacks with RSA ® Mobile Lock, RSA ® Risk AI, and now, RSA Help Desk Live Verify.
RSA Continues Passwordless Innovations
In addition to RSA Help Desk Live Verify, RSA is introducing deep security innovations to strengthen its passwordless offerings:
New RSA Mobile Lock enhancements protect against app tampering, spyware, sideloading, jailbreaking, and AiTM attacks, helping secure passkeys and all authentication methods on both BYOD and managed devices.
Windows Desktop Logon enables new passwordless methods, like QR code scanning and mobile FIDO logon for Windows desktops.
Secure onboarding with ID Verification uses government ID, liveness detection, and Mobile Match to prevent deepfake-based fraud and ensure the person enrolling owns the phone being used.
These solutions are built into RSA ® ID Plus, the industry's most secure hybrid identity security platform. RSAC Conference attendees can schedule a demo to preview these new innovations at Booth N-6253. They are invited to join RSA CISO Rob Hughes' RSA Conference session on Tuesday, April 29 at 11:40 AM PT to learn how to deploy secure passwordless within Microsoft Entra and other third-party technologies and leverage NIST guidance to implement suitable passwordless strategies.
About RSA
RSA provides mission-critical cybersecurity solutions that protect the world's most security-sensitive organizations. The RSA Unified Identity Platform provides true passwordless identity security, risk-based access, automated identity intelligence, and comprehensive identity governance across cloud, hybrid, and on-premises environments. More than 9,000 high-security organizations trust RSA to manage more than 60 million identities, detect threats, secure access, and enable compliance. For additional information, visit our website to contact sales, find a partner, or learn more about RSA.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ASICS GT-2160 'Black/Morpho' Delivers Bold Contrast and Retro Appeal
ASICS GT-2160 'Black/Morpho' Delivers Bold Contrast and Retro Appeal

Hypebeast

timean hour ago

  • Hypebeast

ASICS GT-2160 'Black/Morpho' Delivers Bold Contrast and Retro Appeal

Name:ASICS GT-2160 'Black/Morpho'Colorway:'Black/Morpho'SKU:1203A275-003MSRP:$130 USDRelease Date:Available NowWhere to Buy:ASICS TheASICSGT-2160receives a vibrant and intriguing addition with its new 'Black/Morpho' colorway. This iteration continues to pay homage to the technical design language of the GT-2000 series from the early 2010s, while its colorway draws inspiration from the striking black morpho tetra fish. The silhouette combines a stealthy black mesh upper with vivid green and blue overlays, creating a bold visual contrast that highlights the shoe's intricate details. Metallic silver elements are strategically incorporated into the design, further elevating the visual appeal, all sitting atop an off-white sole unit that completes the dynamic look. Emblematic features from the GT-2000 are also carried over, including a segmented midsole structure and visible GEL® technology inserts. This combination not only creates an industrial aesthetic but also provides advanced cushioning properties, enhancing comfort.

KiWear Unveils Smart Ring Input Solution for AI Glasses in Collaboration with Qualcomm at AWE USA 2025
KiWear Unveils Smart Ring Input Solution for AI Glasses in Collaboration with Qualcomm at AWE USA 2025

Yahoo

timean hour ago

  • Yahoo

KiWear Unveils Smart Ring Input Solution for AI Glasses in Collaboration with Qualcomm at AWE USA 2025

Collaboration addresses interactive solutions for smart glasses as global smart glasses shipments surge 210%i year-over-year LONG BEACH, Calif., June 10, 2025--(BUSINESS WIRE)--KiWear, Inc. today announced a reference design for a smart ring input solution for use with smart glasses and AI glasses during Qualcomm Technologies, Inc.'s opening keynote presentation at AWE USA 2025. The collaboration aims to help OEMs develop interactive solutions for AI smart glass partners. Industry analysts expect 60% year-over-year growth in 2025 and a sustained CAGR of over 60% through 2029. "Qualcomm Technologies is fueling the AI glasses industry with our Snapdragon® XR Platforms. KiWear's smart ring, featuring algorithms co-developed with Qualcomm Technologies, makes an ideal input device for smart glasses and AI glasses," said Ziad Asghar, SVP & GM of XR at Qualcomm Technologies, Inc. "This new reference design represents a step forward in helping OEMs to deliver solutions that enable intuitive and discreet gesture based interaction for the growing category of AI smart glasses. "We are thrilled to build next generation input solutions for both AI and XR together with industry leaders such as Qualcomm," said Chris Shi, Founder and CEO of KiWear, Inc. Leading HCI Innovation KiWear, recognized as a leader in HCI innovations, has developed cutting-edge smart ring technology that enables seamless hand-centric interactions with smart glasses and AI glasses. The company's solutions address fundamental input challenges that have limited widespread smart glasses adoption. Founded in April 2025, KiWear is a Delaware-based company delivering comprehensive HCI solutions for multi-DoF controllers, smart rings, and wearables. The company brings together prominent computer vision scientists, AI/XR integration experts, and hardware/software innovators, with expertise spanning conceptualization to mass production. KiWear has forged collaborations and delivers exclusive solutions to six of the global top 10 consumer electronics leaders. With R&D hubs in Shanghai and Beijing beyond its U.S. headquarters, the company partners with premier technology conglomerates to enable natural HCI solutions for next-generation XR and AI products. Live Demonstrations Conference attendees can experience KiWear's smart ring and watch technologies at the Qualcomm Technologies' booth (Booth 209) during AWE USA, showcasing seamless integration with smart glasses platforms. Snapdragon is a trademark or registered trademark of Qualcomm Incorporated. Snapdragon branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries. __________________________ i Source: View source version on Contacts Media Contact:Sally GaoKiWear +86-13918187350

Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics
Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics

Yahoo

timean hour ago

  • Yahoo

Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics

- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug discovery programs for the generation of small molecule drugs. SEOUL, South Korea, June 11, 2025 /PRNewswire/ -- Swedish biotech company Salipro Biotech AB today announced that it has entered into a research collaboration with Daewoong Pharmaceutical Co., Ltd. Daewoong Pharmaceutical gains access to Salipro Biotech's expertise and Salipro® platform for stabilizing challenging membrane proteins (e.g., GPCRs, ion channels, transporters). The collaboration will target a specific membrane protein to aid Daewoong's development of novel small molecule drugs. Under the terms of this agreement, the collaboration will enable Daewoong Pharma to leverage Salipro Biotech´s expertise and proprietary platform to advance their drug discovery efforts in the development of novel therapeutic small molecules against a challenging membrane protein drug target. "We are excited to join forces with Daewoong Pharmaceutical and contribute with our proprietary Salipro® platform to accelerate the development of novel therapeutic drugs for Daewoong Pharmaceutical's pipeline", said Jens Frauenfeld, CEO of Salipro Biotech. "This partnership is particularly significant as it marks our first collaboration with a partner in South Korea, underscoring the global application and versatility of our expertise and platform to make the undruggable druggable." Seongsoo Park, CEO at Daewoong Pharmaceutical stated, "Collaborating with Salipro Biotech and accessing their Salipro® platform aligns with our goal to address complex drug targets. Salipro's expertise in membrane protein stabilization will benefit our research for novel small molecule therapeutics, and we look forward to the results of our joint efforts." About Salipro Biotech ABSalipro Biotech AB is a privately held biotech company focused on unlocking challenging drug targets for the development of next-generation therapeutics. The company is headquartered in Stockholm, Sweden with a fully owned IP portfolio that covers the Salipro® platform technology for the stabilization of membrane proteins. The majority of drug targets are so-called membrane proteins; however, these targets are inherently unstable and challenging to investigate. The proprietary Salipro® technology stabilizes membrane proteins in their native forms, enabling them to be employed in drug discovery programs for therapeutic antibodies, small molecule drugs and structure-based drug design. To date, Salipro Biotech has signed multiple research collaborations with top-tier pharma and biotech companies. Through in-house and partnered pipelines, Salipro Biotech AB accelerates the discovery of novel drugs. About Daewoong PharmaceuticalDaewoong Pharmaceutical (KRX: established in 1945, is a global pharmaceutical company based in South Korea. The company is committed to the development, manufacturing, and commercialization of pharmaceutical products, with a mission to provide the most beneficial total solutions, including pharmaceuticals and services, which contribute to improving the quality of life of valued consumers. Operating with a keen focus on both domestic and international markets, Daewoong Pharmaceutical specializes in developing treatments for intractable and rare diseases. The company's diverse portfolio encompasses novel drugs, biologics, new products, and C&D, all supported by in-house research and development, open collaboration, and advanced manufacturing facilities. Marking significant achievements in drug development, Daewoong Pharmaceutical has successfully developed novel drugs for GERD, featuring the active ingredient Fexuprazan, and for Type 2 diabetes, with the active ingredient Enavogliflozin, in two consecutive years. The company is currently advancing in the development of First-in-Class Oral Anti-Fibrotic Agent for Idiopathic Pulmonary Fibrosis, utilizing Bersiporocin as a PRS Inhibitor. Notably, Bersiporocin has been designated by the U.S. FDA as an orphan drug and a Fast Track development product. View original content to download multimedia: SOURCE Daewoong Pharmaceutical Co., Ltd.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store